Emmaus Life Sciences, Inc. ( EMMA) - Key Metrics
EMMA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
EMMA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
EMMA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -32.67% | ? |
| 2025Q4 | 265.34% | ? |
| 2025Q3 | 58.22% | ? |
| 2025Q2 | -350.38% | ? |
| 2025Q1 | 25.55% | ? |
EMMA
Price: $0.01
52 week price:
Earnings Per Share: -0.12 USD
P/E Ratio: -0.12
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30500
Market Capitalization: 617657